Lacticaseibacillus Rhamnosus LRa05 for Alleviating Allergic Rhinitis in Children

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
Allergic Rhinitis (AR)
Interventions
DIETARY_SUPPLEMENT

probiotic product

During the study, subjects take one sachet of Lactobacillus rhamnosus LRa05 daily. Evaluation is conducted by monitoring the subjects' nasal symptoms and gut microbiota before and after the intervention.

DIETARY_SUPPLEMENT

Maltodextrin

During the study, subjects in the control group take one sachet of maltodextrin daily with 3.0g. Evaluation is conducted by monitoring the subjects' nasal symptoms and gut microbiota before and after the 8-week trial.

Trial Locations (1)

250012

Qilu Hospital of Shangdong University, Jinan

All Listed Sponsors
lead

Wecare Probiotics Co., Ltd.

INDUSTRY